Am new to this community so hi!
Feel it's crucial to share an important experience regarding my ongoing care and monitoring.
For some time, I have been under active surveillance following a diagnosis of small, low-grade prostate cancer. As part of this protocol, I have undergone routine PSA blood tests, with the results sent to both my GP and my consultant. For a period, my GP reviewed these figures and consistently advised that no immediate action was required. However, after experiencing multiple rescheduled appointments with my consultant over the past year [I know they're busy but…], I finally managed to see him early this year.
During the consultation, he reviewed my recent PSA levels and pointed out a critical detail: because I am taking Finasteride, my actual PSA score needs to be doubled to reflect a true baseline. Because this adjustment had not been accounted for previously by the GP, he ordered an MRI scan. The subsequent MRI revealed a new area of concern on the prostate that was not visible on prior imaging. This prompted a follow-up biopsy, which confirmed that the cancer has expanded and now requires active medical treatment.
I am sharing this to raise awareness: if you are undergoing PSA screening or surveillance and are currently prescribed Finasteride, please verify that your 'healthcare team' is doubling your PSA values when interpreting the results. While it is uncertain whether earlier detection would have altered my current treatment plan, ensuring that PSA scores are accurately evaluated is essential knowledge for anyone managing their prostate health.
K